sammibi 1 mg beredningssats för radioaktivt läkemedel
sestamibi radiofarma bacon
laboratorios bacon saic - tetrafloruro de tetrakis (2-metoxi sobutil isonitrilo) de cobre (i) - tetrafloruro de tetrakis (2-metoxi sobutil isonitrilo) de cobre (i)....0.5 mg
stamicis 1 mg radiofarmaceutisk præparationssæt
kit for the preparation of technetium tc99m sestamibi- technetium tc-99m sestamibi injection
sun pharmaceutical industries, inc. - technetium tc-99m sestamibi (unii: 971z4w1s09) (technetium tc-99m sestamibi - unii:971z4w1s09) - technetium tc-99m sestamibi 1 mg in 10 ml - myocardial imaging: technetium tc 99m sestamibi injection is a myocardial perfusion agent that is indicated for detecting coronary artery disease by localizing myocardial ischemia (reversible defects) and infarction (non-reversible defects), in evaluating myocardial function and developing information for use in patient management decisions. technetium tc 99m sestamibi evaluation of myocardial ischemia can be accomplished with rest and cardiovascular stress techniques (e.g., exercise or pharmacologic stress in accordance with the pharmacologic stress agent’s labeling). it is usually not possible to determine the age of a myocardial infarction or to differentiate a recent myocardial infarction from ischemia. breast imaging: technetium tc 99m sestamibi is indicated for planar imaging as a second line diagnostic drug after mammography to assist in the evaluation of breast lesions in patients with an abnormal mammogram or a palpable breast mass. technetium tc 99m sestamibi is not indicated for breast cancer scree
stamicis 1 mg kit for radiopharm. prep. i.v. vial
cis bio international - copper tetramibi tetrafluoroborate 1 mg - kit for radiopharmaceutical preparation - 1 mg - tetrakis (2-methoxy-2-methylpropyl-1-isocyanide) copper (i) tetrafluoroborate 1 mg - technetium (99mtc) sestamibi
technescan sestamibi 1 mg kit for radiopharm. prep. i.v. vial
curium netherlands b.v. - copper tetramibi tetrafluoroborate 1 mg - kit for radiopharmaceutical preparation - 1 mg - tetrakis (2-methoxy-2-methylpropyl-1-isocyanide) copper (i) tetrafluoroborate 1 mg - technetium (99mtc) sestamibi
technetium tc 99m sestamibi injection, powder, for solution
jubilant draximage (usa) inc. - technetium tc-99m sestamibi (unii: 971z4w1s09) (technetium tc-99m sestamibi - unii:971z4w1s09) - tetrakis(2-methoxyisobutylisocyanide)copper(i) tetrafluoroborate 1 mg in 1 ml - myocardial imaging: kit for the preparation of technetium tc 99m sestamibi injection is a myocardial perfusion agent that is indicated for detecting coronary artery disease by localizing myocardial ischemia (reversible defects) and infarction (non-reversible defects), in evaluating myocardial function and developing information for use in patient management decisions. technetium tc 99m sestamibi evaluation of myocardial ischemia can be accomplished with rest and cardiovascular stress techniques (e.g., exercise or pharmacologic stress in accordance with the pharmacologic stress agents labeling). it is usually not possible to determine the age of a myocardial infarction or to differentiate a recent myocardial infarction from ischemia. breast imaging: kit for the preparation of technetium tc 99m sestamibi injection is indicated for planar imaging as a second line diagnostic drug after mammography to assist in the evaluation of breast lesions in patients with an abnormal mammogram or a palpable breast mass. kit f
technetium tc 99m sestamibi injection
jubilant hollisterstier general partnership - technetium tc-99m sestamibi (unii: 971z4w1s09) (technetium tc-99m sestamibi - unii:971z4w1s09) - tetrakis(2-methoxyisobutylisocyanide)copper(i) tetrafluoroborate 1 mg in 10 ml
apleek transdermal patch
bayer limited - ethinylestradiol gestodene - transdermal patch
apleek 60 micrograms/24 hours + 13 micrograms/24 hours transdermal patch
bayer plc - gestodene 2.1 mg, ethinylestradiol 0.55 mg - transdermal patch